Progyny (PGNY) Reiterated at Market Outperform by Citizens as Addressable Market Grows

September 2, 2026 4:19 AM EDT Send to a Friend
Citizens analyst Constantine Davides reiterated a Market Outperform rating and $31.00 price target on Progyny (NASDAQ: PGNY).The analyst commented, "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login